We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Avalo Therapeutics Inc | NASDAQ:AVTX | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.215 | -2.07% | 10.175 | 10.06 | 10.24 | 10.39 | 10.0001 | 10.18 | 12,938 | 20:17:53 |
001-37590 | 45-0705648 | |||||||
(Commission File Number) | (IRS Employer Identification No.) |
Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||
Common Stock, $0.001 Par Value | AVTX | Nasdaq Capital Market |
Name | For | Withheld | Broker Non-Votes | |||||||||||||||||
Steven Boyd | 68,399,932 | 2,848,966 | — | |||||||||||||||||
June Almenoff, M.D., Ph.D. | 63,063,363 | 8,185,535 | — | |||||||||||||||||
Mitchell Chan | 68,537,941 | 2,710,957 | — | |||||||||||||||||
Gilla Kaplan, Ph.D. | 68,510,640 | 2,738,258 | — | |||||||||||||||||
Keith Maher, M.D. | 68,520,255 | 2,728,643 | — | |||||||||||||||||
Garry Neil, M.D. | 67,093,097 | 4,155,801 | — | |||||||||||||||||
Magnus Persson, M.D., Ph.D. | 66,987,263 | 4,261,635 | — |
For | Against | Abstain | Broker Non-Votes | |||||||||||||||||
78,835,080 | 4,329,952 | 906,099 | — | |||||||||||||||||
For | Against | Abstain | Broker Non-Votes | |||||||||||||||||
66,230,263 | 4,535,881 | 482,754 | 12,822,233 | |||||||||||||||||
1 Year | 2 Years | 3 Years | Abstain | Broker Non-Votes | ||||||||||||||||||||||
20,732,641 | 54,282 | 48,133,318 | 2,328,657 | — | ||||||||||||||||||||||
For | Against | Abstain | Broker Non-Votes | |||||||||||||||||
82,986,379 | 462,649 | 622,103 | — | |||||||||||||||||
AVALO THERAPEUTICS, INC. | |||||||||||
Date: June 14, 2022 | By: | /s/ Christopher Sullivan | |||||||||
Christopher Sullivan | |||||||||||
Chief Financial Officer |
1 Year Avalo Therapeutics Chart |
1 Month Avalo Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions